Exciting early indications of a cure for Hepatitis C do not mean we should become complacent about the risks of contracting the debilitating disease, a leading Australian researcher warns.
Professor Geoff McCaughan, right, head of the Liver Immunobiology Program at Sydney’s Centenary Institute of medical research, says preliminary results of a newly developed oral treatment regime for liver transplant patients with Hepatitis C were showing promising results.
Congratulations to Professor Geoff McCaughan the head of Centenary’s Liver Injury and Cancer research program and director of the Australian National Liver Transplant Unit at the Royal Prince Alfred Hospital who has won this year’s Distinguished Service Award of the International Liver Transplantation Society (ILTS).
The award was presented today at ILTS’s International Conference held in Sydney and has been presented annually since 1993 to a member of the Society who has demonstrated outstanding service to ILTS and is a recognized leader in the area of liver transplantation. The list reads like a Who’s Who of transplantation.